Description
CJC-1295 + Ipamorelin – Synergistic Growth Hormone Research Blend
CJC-1295 + Ipamorelin (5 mg + 5 mg) is a powerful growth hormone–releasing peptide combination designed for research on pituitary function, cellular regeneration, and metabolic enhancement. This synergistic formulation combines CJC-1295, a long-acting GHRH analog, with Ipamorelin, a selective GHRP (Growth Hormone Releasing Peptide), to promote a strong, steady increase in natural growth hormone (GH) secretion without affecting cortisol or prolactin levels.
This dual-peptide blend is widely used in research studying anti-aging mechanisms, muscle growth, fat metabolism, recovery, and sleep quality through the stimulation of endogenous GH release.
Key Features & Research Applications
💪 Synergistic GH Release:
CJC-1295 stimulates the pituitary to release growth hormone over time, while Ipamorelin triggers rapid GH pulses — resulting in sustained and balanced GH elevation.
⚡ Muscle Growth & Recovery:
Supports studies on lean muscle development, protein synthesis, and accelerated recovery after injury or exercise.
🔥 Fat Metabolism:
Promotes lipolysis (fat breakdown), making it a focus in research exploring metabolic optimization and body composition.
🧠 Regeneration & Sleep Studies:
Improves recovery, deep sleep quality, and tissue repair in preclinical models.
❤️ Longevity & Anti-Aging Research:
Explored for its potential to enhance cellular regeneration, collagen production, and overall metabolic health.
Product Details
-
Name: CJC-1295 + Ipamorelin
-
Form: Lyophilized powder blend (dual peptide)
-
Composition: 5 mg CJC-1295 + 5 mg Ipamorelin per vial
-
Molecular Formula (CJC-1295): C₁₅₂H₂₅₂N₄₄O₄₂
-
Molecular Formula (Ipamorelin): C₃₈H₄₉N₉O₅
-
Purity: ≥ 98% (HPLC verified)
-
Appearance: White to off-white lyophilized powder
-
Storage: Store in a cool, dry place; refrigerate (35.6–46.4°F) after reconstitution.
-
Packaging: Sterile, sealed vial for laboratory research.
-
Verification: Third-party tested for purity, potency, and identity.


